The Best Stocks to Invest $50,000 In Right Now

Source Motley_fool

Key Points

  • Google parent Alphabet is well-positioned to win in the AI, cloud, robotaxi, and quantum computing markets.

  • Dominion Energy is a backdoor AI play with a stable business and juicy dividend.

  • Vertex Pharmaceuticals' existing products and pipeline programs should enable it to deliver strong growth.

  • 10 stocks we like better than Vertex Pharmaceuticals ›

Where should I put my money? That's the question every investor must answer. The challenge is that there are thousands of alternatives. Which of those alternatives is most attractive will vary based on whom you ask.

Like many other observers of the investing world, I have my opinions. Here are three of the best stocks to invest $50,000 in right now, in my view.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

A person looking up at chalk drawings of light bulbs with one containing a dollar sign.

Image source: Getty Images.

1. Alphabet

Sometimes, choosing the ideal stocks to buy boils down to finding companies that have a good chance of winning in markets likely to grow tremendously in the future. I think Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is a great example of such a company.

It's a near certainty that artificial intelligence (AI) will have a bigger impact over the next few years than it does today. Alphabet is an AI pioneer. The company's soon-to-be-released Google Gemini 3.0 large language model (LLM) could further cement its AI leadership.

The scramble to harness the power of AI should accelerate the shift from on-premises hosting of applications and data to cloud hosting. Alphabet's Google Cloud already ranks as the fastest-growing major cloud services provider. It's poised to be a huge beneficiary of surging cloud adoption over the next several years.

Alphabet is also a major player in key emerging technologies. Its Waymo unit is the leader in the rapidly expanding robotaxi market. Google Quantum AI hopes to develop a useful, large-scale quantum computer within the decade.

2. Dominion Energy

I view Dominion Energy (NYSE: D) as a kind of backdoor way to profit from the AI boom. The data centers that house AI applications consume enormous amounts of power. Virginia, where Dominion is headquartered, is home to the world's largest data center market.

Dominion's business isn't all about AI, though. The company provides electricity to around 3.6 million homes and businesses in three states: Virginia, North Carolina, and South Carolina. Dominion also provides natural gas to roughly 500,000 customers in South Carolina.

One key reason why I like Dominion Energy right now is that it could be a safe haven if the economy and/or stock market stumbles. Utility stocks tend to hold up well during turbulent periods. Even though Dominion's stock has jumped by a double-digit percentage this year, it's still reasonably valued with a forward price-to-earnings ratio of 17.

Income investors should especially love Dominion's dividend yield of 4.4%. I fully expect more dividend increases will be on the way from this utility giant.

3. Vertex Pharmaceuticals

Vertex Pharmaceuticals (NASDAQ: VRTX) has been one of my favorite stocks for a while. There's a lot to like about this big biotech company.

For one thing, Vertex enjoys a monopoly in treating the underlying cause of cystic fibrosis (CF). While this kind of market dominance doesn't last forever in the biopharmaceutical world, the company should be well-positioned for years to come. Vertex's patents on its most powerful CF therapy, Alyftrek, don't expire until 2039. The nearest potential rival to the drugmaker's CF therapies is only in phase 2 clinical trials.

Vertex's CF franchise ensures the company will have a steady revenue stream and significant profitability. However, its growth should come from other products. I put Journavx at the top of the list. It's a non-opioid pain drug that's both safe and effective. Journavx seems likely to become Vertex's first blockbuster drug in years outside of CF.

I'm especially enthusiastic about Vertex's pipeline. The company could file for regulatory approvals for two new drugs next year: zimislecel in treating severe type 1 diabetes and povetacicept in treating IgA nephropathy. Vertex also has other promising late-stage candidates, notably including inaxaplin, which targets APOL1-mediated kidney disease.

Should you invest $1,000 in Vertex Pharmaceuticals right now?

Before you buy stock in Vertex Pharmaceuticals, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $602,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,105,092!*

Now, it’s worth noting Stock Advisor’s total average return is 1,028% — a market-crushing outperformance compared to 190% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of October 20, 2025

Keith Speights has positions in Alphabet, Dominion Energy, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Alphabet and Vertex Pharmaceuticals. The Motley Fool recommends Dominion Energy. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
MicroStrategy Chair Michael Saylor Breaks 13-Week Bitcoin Buying RitualStrategy (MicroStrategy) may have skipped its weekly Bitcoin (BTC) purchase for the first time since late December, potentially ending a 13-week accumulation streak.Executive Chair Michael Saylor did
Author  Beincrypto
Mar 30, Mon
Strategy (MicroStrategy) may have skipped its weekly Bitcoin (BTC) purchase for the first time since late December, potentially ending a 13-week accumulation streak.Executive Chair Michael Saylor did
placeholder
Solana Price Outlook: What To Expect From SOL In April 2026Solana (SOL) price enters April 2026 under pressure. March is closing at roughly -0.88%, extending a red streak that now stretches six consecutive months since October 2025.A head-and-shoulders breakd
Author  Beincrypto
Mar 31, Tue
Solana (SOL) price enters April 2026 under pressure. March is closing at roughly -0.88%, extending a red streak that now stretches six consecutive months since October 2025.A head-and-shoulders breakd
placeholder
3 Meme Coins To Watch In April 2026April 2026 brings a fresh set of meme coins to watch as technical setups, derivatives shifts, and concentrated wallet structures create potential turning points across multiple tokens.BeInCrypto analy
Author  Beincrypto
Mar 31, Tue
April 2026 brings a fresh set of meme coins to watch as technical setups, derivatives shifts, and concentrated wallet structures create potential turning points across multiple tokens.BeInCrypto analy
placeholder
SpaceX plans a $70-75 billion IPO at a $1.75 trillion valuationSpaceX is pushing for what could be the biggest stock offering ever. But there’s a problem with the timing. Reports last week said the company plans to file IPO paperwork as soon as this week. They want to raise $70-$75 billion, with the company valued at $1.75 trillion. Those are massive numbers that would shatter […]
Author  Cryptopolitan
Mar 31, Tue
SpaceX is pushing for what could be the biggest stock offering ever. But there’s a problem with the timing. Reports last week said the company plans to file IPO paperwork as soon as this week. They want to raise $70-$75 billion, with the company valued at $1.75 trillion. Those are massive numbers that would shatter […]
placeholder
If the US Troops Enter Iran, What Happens to Bitcoin? Lessons From Past WarsMarkets are already reacting to rising geopolitical risk. Several Polymarket insiders who successfully bet on the start date of the Iran war are now betting heavily on US boots on the ground in Iran.N
Author  Beincrypto
2 hours ago
Markets are already reacting to rising geopolitical risk. Several Polymarket insiders who successfully bet on the start date of the Iran war are now betting heavily on US boots on the ground in Iran.N
goTop
quote